Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 72971 SAN FRANCISCO, CA
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$165,142
+$164,692 QoQ
Shares Held
16,903
+38315.9% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 96 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. KPTI ranks #265 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in KPTI

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $165,142 16,903
2024-12-31 $450 666
2024-09-30 $552 666
2024-06-30 $12 14
2024-03-31 $51,185 33,898
2023-12-31 $25,400 29,365
2023-09-30 $30,394 22,683
2023-06-30 $84,518 47,217
2023-03-31 $652,123 167,641
2022-12-31 $414 122
2022-09-30 $30,836 5,648
2022-06-30 $30,897 6,851
2022-03-31 $301,255 40,876
2021-12-31 $423,529 65,868
2021-09-30 $147,768 25,390
2021-06-30 $316,369 30,656
2021-03-31 $1,100,159 104,578
2020-12-31 $2,492,634 161,023
2020-09-30 $2,613,516 179,008
2020-06-30 $3,424,236 180,794
2020-03-31 $1,218,086 63,409